Kisner DL - Search Results

1

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.

Sarosy GA, Brown TD, Von Hoff DD, Spiegel RJ, Golando JP, Beougher KL, Kuhn JG, Kisner DL. Sarosy GA, et al. Among authors: kisner dl. Cancer Res. 1986 Oct;46(10):5368-71. Cancer Res. 1986. PMID: 3756887

2

Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic.

Dorr FA, Von Hoff DD, Kuhn JG, Schwartz R, Kisner DL. Dorr FA, et al. Among authors: kisner dl. Cancer Res. 1986 May;46(5):2562-5. Cancer Res. 1986. PMID: 2938729

3

Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.

Von Hoff DD, Sarosy G, Brown TD, Kuhn JG, Kisner DL. Von Hoff DD, et al. Among authors: kisner dl. Semin Oncol. 1986 Sep;13(3 Suppl 2):72-7. Semin Oncol. 1986. PMID: 3764442

4

Doxorubicin and interferon: rationale and clinical experience.

Green MD, Speyer J, Wernz J, Kisner D, Koeller J, Blum R, Von Hoff D, Muggia F. Green MD, et al. Cancer Treat Rev. 1985 Dec;12 Suppl B:61-7. Cancer Treat Rev. 1985. PMID: 3833329 No abstract available.

5

A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer.

Weiss GR, Hersh M, Kuhn JG, Ludden TM, von Hoff DD, Kisner DL, Pirtle TE 3rd. Weiss GR, et al. Among authors: kisner dl. Cancer Chemother Pharmacol. 1985;15(2):144-8. doi: 10.1007/BF00257525. Cancer Chemother Pharmacol. 1985. PMID: 4017163

6

Elliptinium, a DNA intercalating agent with broad antitumor activity in a human tumor cloning system.

Arteaga CL, Kisner DL, Goodman A, von Hoff DD. Arteaga CL, et al. Among authors: kisner dl. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1621-6. doi: 10.1016/0277-5379(87)90440-8. Eur J Cancer Clin Oncol. 1987. PMID: 3428332

7

Interferon-alpha therapy of renal cancer.

Neidhart JA, Gagen MM, Young D, Tuttle R, Melink TJ, Ziccarrelli A, Kisner D. Neidhart JA, et al. Cancer Res. 1984 Sep;44(9):4140-3. Cancer Res. 1984. PMID: 6378379 Clinical Trial.

8

Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.

Leavitt RD, Ratanatharathorn V, Ozer H, Ultmann JE, Portlock C, Myers JW, Kisner D, Norred S, Spiegel RJ, Bonnem EM. Leavitt RD, et al. Semin Oncol. 1987 Jun;14(2 Suppl 2):18-23. Semin Oncol. 1987. PMID: 3589702 No abstract available.

9

Activity of Carbetimer in a human tumor cloning system.

Kisner DL, Mehta P, Paget GE, Von Hoff DD. Kisner DL, et al. Invest New Drugs. 1984;2(1):55-8. doi: 10.1007/BF00173787. Invest New Drugs. 1984. PMID: 6469499

10

Phase I clinical trial of carbetimer.

Hanauske AR, Melink TJ, Harman GS, Clark GM, Craig JB, Koeller JM, Boldt DH, Kantor B, Kisner DL, Orczyk G, et al. Hanauske AR, et al. Among authors: kisner dl. Cancer Res. 1988 Sep 15;48(18):5353-7. Cancer Res. 1988. PMID: 2842047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters